# Asciminib With or Without Sildenafil for Brain Tumors

> **NCT07039760** · EARLY_PHASE1 · NOT_YET_RECRUITING · sponsor: **Washington University School of Medicine** · enrollment: 12 (estimated)

## Conditions studied

- Brain Tumor

## Interventions

- **DRUG:** Asciminib
- **DRUG:** Sildenafil
- **PROCEDURE:** Surgical resection or biopsy

## Key facts

- **NCT ID:** NCT07039760
- **Lead sponsor:** Washington University School of Medicine
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-04-30
- **Primary completion:** 2027-10-31
- **Final completion:** 2027-11-30
- **Target enrollment:** 12 (ESTIMATED)
- **Last updated:** 2026-03-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07039760

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07039760, "Asciminib With or Without Sildenafil for Brain Tumors". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT07039760. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*